Sore Throat Logenzes Lozenge
NDC Package 0904-6255-49

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Sore Throat Logenzes (benzocaine and menthol) lozenges is adults and children 5 years or older: allow lozenge to dissolve slowly in the mouth; may be repeated every 2 hours as needed or as directed by a doctor or dentist. This formulation utilizes a lozenge delivery system. Marketed by Major Pharmaceuticals, this product is identified by NDC 0904-6255 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
0904-6255-49
Package Description
18 BLISTER PACK in 1 CARTON / 18 LOZENGE in 1 BLISTER PACK
Product Code
0904-6255
11-Digit Billing Format
00904625549
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
18 EA
RxNorm Crosswalk
RxCUI: 824574 - benzocaine 15 MG / menthol 3.6 MG Oral Lozenge

Clinical Specifications

Proprietary Name
Sore Throat Logenzes Sore Throat
Non-Proprietary Name
Benzocaine And Menthol
Substance Name
Benzocaine; Menthol
Dosage Form
Lozenge - A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Adults and children 5 years or older: allow lozenge to dissolve slowly in the mouth; may be repeated every 2 hours as needed or as directed by a doctor or dentist. children under 5 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
Major Pharmaceuticals
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-28-2012
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0904-6255-49 identifies a specific commercial package of 18 blister pack in 1 carton / 18 lozenge in 1 blister pack of Sore Throat Logenzes Sore Throat, a human over the counter drug labeled by Major Pharmaceuticals. This lozenge is formulated for oral use and contains benzocaine; menthol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Major Pharmaceuticals on December 28, 2012. The current certification is valid through December 31, 2027.

How is this Major Pharmaceuticals product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00904625549. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 18 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0904-6255-49
11-Digit CMS (5-4-2)
00904-6255-49

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.